Omics-derived hepatocellular carcinoma risk biomarkers for precision care of chronic liver diseases

Naoto Fujiwara, Tongqi Qian, Bhuvaneswari Koneru, Yujin Hoshida

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations


Precise hepatocellular carcinoma (HCC) risk prediction will play increasingly important roles with the contemporary HCC etiologies, that is, non-alcoholic fatty liver disease and resolved hepatitis C virus infection. Because the HCC incidence rate in this emerging patient population is relatively low (~1% per year), identification of a subset of patients at the highest risk is critical to concentrate the effort and resources of regular HCC screening to those who most need it. Omics profiling has been derived using several candidate HCC risk biomarkers, which could refine HCC screening by enabling individual risk-based personalized or risk-stratified patient management. Various types of biomolecules have been explored as sources of information to predict HCC risk at various time horizons. Germline DNA polymorphisms likely reflect race/ethnicity- and/or etiology-specific susceptibility to HCC development or chronic liver disease progression toward carcinogenesis. Transcriptomic dysregulations in the diseased liver capture functional molecular status supporting oncogenesis such as inflammatory pathway and myofibroblast activation. Circulating nucleic acids, proteins, and metabolites could serve as less-invasive measures of molecular HCC risk. Characterization of gut microbiota could also inform HCC risk estimation. Each biomarker could have its niche of clinical application depending on logistics of use, performance, and costs with a goal to eventually improve patient prognosis as a part of the whole algorithm of chronic liver disease management.

Original languageEnglish (US)
Pages (from-to)817-830
Number of pages14
JournalHepatology Research
Issue number7
StatePublished - Jul 1 2020


  • biomarker
  • hepatocellular carcinoma
  • omics
  • precision medicine

ASJC Scopus subject areas

  • Hepatology
  • Infectious Diseases


Dive into the research topics of 'Omics-derived hepatocellular carcinoma risk biomarkers for precision care of chronic liver diseases'. Together they form a unique fingerprint.

Cite this